3 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
Follow Cancer of Stomach: new trials by email Literature Review of Cancer of Stomach trials Research Report on Cancer of Stomach
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial Oral Vioxx (Rofecoxib) - Cancer of Stomach | Phase 3 | Unknown | Chinese University of Hong Kong | 214 | 2004-10-01 | 2005-11-17 |
| Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial Vioxx (Rofecoxib) - Cancer of Stomach | Phase 3 | Unknown | Chinese University of Hong Kong | 206 | 2004-10-01 | 2005-12-09 |
| Role of Routine Nasogastric Decompression After Subtotal Gastrectomy nasogastric tube - Cancer of Stomach | Phase 3 | Unknown | Chinese University of Hong Kong | 90 | 2004-09-01 | 2005-09-14 |
Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Stomach Diseases (3)
rofecoxib (2) · Enteral Nutrition (1)
Chinese University of Hong Kong (3)
China (3)